Nationwide Fund Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-4,000
| Closed | -$372K | – | 286 |
|
|
2017
Q3 | $372K | Sell |
4,000
-26,800
| -87% | -$2.49M | ﹤0.01% | 2324 |
|
|
2017
Q2 | $2.8M | Hold |
30,800
| – | – | 0.01% | 1283 |
|
|
2017
Q1 | $2.7M | Buy |
30,800
+1,000
| +3% | +$87.8K | 0.01% | 1273 |
|
|
2016
Q4 | $2.47M | Sell |
29,800
-32,500
| -52% | -$2.69M | 0.01% | 1317 |
|
|
2016
Q3 | $5.76M | Buy |
62,300
+300
| +0.5% | +$27.8K | 0.02% | 897 |
|
|
2016
Q2 | $4.82M | Buy |
62,000
+30,000
| +94% | +$2.33M | 0.02% | 958 |
|
|
2016
Q1 | $2.64M | Sell |
32,000
-40,177
| -56% | -$3.31M | 0.01% | 1224 |
|
|
2015
Q4 | $7.56M | Sell |
72,177
-68,813
| -49% | -$7.21M | 0.03% | 710 |
|
|
2015
Q3 | $14.8M | Sell |
140,990
-34,968
| -20% | -$3.68M | 0.07% | 365 |
|
|
2015
Q2 | $24.1M | Buy |
175,958
+9,440
| +6% | +$1.29M | 0.1% | 232 |
|
|
2015
Q1 | $20.8M | Sell |
166,518
-54,920
| -25% | -$6.84M | 0.08% | 291 |
|
|
2014
Q4 | $20M | Sell |
221,438
-26,510
| -11% | -$2.4M | 0.09% | 290 |
|
|
2014
Q3 | $17.9M | Buy |
247,948
+82,000
| +49% | +$5.92M | 0.08% | 318 |
|
|
2014
Q2 | $10.3M | Sell |
165,948
-62,740
| -27% | -$3.9M | 0.04% | 558 |
|
|
2014
Q1 | $15.6M | Buy |
228,688
+92,540
| +68% | +$6.31M | 0.07% | 344 |
|
|
2013
Q4 | $9.57M | Buy |
136,148
+27,496
| +25% | +$1.93M | 0.04% | 591 |
|
|
2013
Q3 | $7.85M | Sell |
108,652
-18,700
| -15% | -$1.35M | 0.04% | 655 |
|
|
2013
Q2 | $7.11M | Buy |
+127,352
| New | +$7.11M | 0.04% | 632 |
|